Discovering new clinical markers in the field of glycomics.
Glycosylation modifications have been reported in a number of disease states and, as a result, there is significant focus on the discovery and development of glycan-based biomarkers. Glyco-biomarkers have the potential to enhance the efficacy and efficiency of the diagnostic procedures for these diseases.
Dublin-Oxford Glycobiology Laboratory, NIBRT-The National Institute for Bioprocessing Research and Training, University College Dublin, Dublin 4, Ireland.
Jayne E
JE
Telford
Margaret A
MA
Doherty
Tharmala
T
Tharmalingam
Pauline M
PM
Rudd
D015415:Biomarkers / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D054794:Glycomics / Q000379:methods*; D006031:Glycosylation; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis / Q000378:metabolism; D011134:Polysaccharides / Q000378:metabolism*
D015415:Biomarkers; D014408:Biomarkers, Tumor; D011134:Polysaccharides